Trending Now
Jazz Pharmaceuticals ($JAZZ) Faces Setback in Essential Tremor Trial, Looks Ahead...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) recently, on June 20th, revealed the outcomes from a Phase 2b clinical trial evaluating suvecaltamide (JZP385), a...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tellurian Inc (TELL) Advances Driftwood LNG Project Amid Financial Flexibility Moves,...
Tellurian Inc. (TELL), closed its last session at $0.8650, matching its opening price for the day. Amidst active trading, today, bids soared...
MAKE IT MODERN
LATEST REVIEWS
Is NBIO a Take-Out Target as Phase 1 Brain Cancer Trial...
One area of the market that has started to clearly outperform over recent months is the Biotechnology space. The iShares Biotechnology ETF...
MAKE IT MODERN
PERFORMANCE TRAINING
ARCA Biopharma Inc. (NASDAQ:ABIO) Announces That It Has Received IND Application Approval For AB201...
ARCA Biopharma Inc. (NASDAQ:ABIO) has announced that it has received FDA approval for its Investigational New Drug application for AB201 (rNAPc2) as a potential...
Liquidia Corp (NASDAQ: LQDA) Will Have a Presentation on YUTREPIA
Liquidia Corporation (NASDAQ: LQDA) has announced a presentation on YUTREPIA studies by Dr Samdeep Sahay. The drug, which is still under investigation, is a...
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second dose cohort in...
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street looks ready to invest in China’s reopening
Strategists predict that China's markets will deliver significant gains to investors this year, as the country's reopening has sparked renewed interest in...
Health Canada Approves SIGA Technologies Inc.’s (NASDAQ: SIGA) TPOXX as a New Drug...
SIGA Technologies Inc. (NASDAQ: SIGA) has received approval from Health Canada for TPOXX as an exceptional use new drug. The regulatory agency has TPOXX...
MAKE IT MODERN
